Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function: A Report of the North American Pediatric Renal Transplant Cooperative Study

Transplantation

Volumn 61, Issue 1, 1996, Pages 31-36

  Jabs, Kathy ^a   Sullivan, E Kenneth ^b   Avner, Ellis D ^c   Harmon, William E ^a   Tejani, Amir ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b EMMES CORPORATION   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; OKT 3; THYMOCYTE ANTIBODY;

ADOLESCENT; AGE; ARTICLE; CADAVER DONOR; CHILD; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DOSE CALCULATION; FEMALE; GRAFT SURVIVAL; GROWTH RETARDATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFANT; KIDNEY; KIDNEY TRANSPLANTATION; MALE; REGRESSION ANALYSIS; STEROIDS;

EID: 0002524569     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601150-00008     Document Type: Article

References (23)

1. Hricik DE, O-Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300.
2. Ingulli E, Tejani A, Markell M. The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children post transplantation in the cyclosporine era. Transplantation 1993; 55: 1029.
3. Reisman L, Lieberman KV, Burrows L, Schanzer H. Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone. Transplantation 1990; 49: 76.
4. Sinclair NR for the Canadian Multicentre Transplant Study Group. Low-dose steroid therapy in cyclosporine-treated transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. Can Med Assoc J 1992; 147: 645.
5. Walker RG, d'Apice AJF, Powell HR, Francis DMA, Kincaid-Smith P. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation. Transplant Proc 1988; 20: 7.
6. Hricik DE, Mayes JT, Schulak JA. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. Am J Kidney Dis 1991; 18: 353.
7. Kupin W, Venkat KK, Oh HK, Dienst S. Complete replacement of methlyprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients. Transplantation 1988; 45: 53.
8. Hricik DE, Lautman J, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. Transplantation 1992; 53: 1232.
9. Tejani A, Butt KMH, Rajpoot D, et al. Strategies for optimizing growth in children with kidney transplants. Transplantation 1989; 47: 229.
10. Curtis JJ, Galla JH, Woodford SY, Lucas BA, Luke RG. Effect of alternate-day prednisone on plasma lipids in renal transplant recipients. Kidney Int 1982; 22: 42.
11. Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy. Clin Nephrol 1976; 5: 123.
12. Guest G, Broyer M. Growth after renal transplantation: correlation with immunosuppressive therapy. Pediatr Nephrol 1991; 5: 143.
13. Tejani A, Fine R, Alexander S, Harmon W, Stablein D. Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study. J Pediatr 1993; 122: 397.
14. Broyer M, Guest G, Gagnadoux MF. Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation. J Pediatr 1992; 120: 721.
15. Drukker A, Turner C, Start K, et al. Hyperlipidemia after renal transplantation in children on alternate day corticosteroid therapy. Clin Nephrol 1986; 26: 140.
16. McEnery PT, Stablein DM, Arbus G, Tejani A. Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study. N Engl J Med 1992; 326: 1727.
17. Leb DE. Alternate-day prednisone treatment may increase kidney transplant rejection. Proc Clin Dial Transplant Forum 1979; 9: 136.
18. Siegel RR, Luke RG, Hellebusch AA. Reduction of toxicity of corticosteroid therapy after renal transplantation. Am J Med 1972; 53: 159.
19. Potter DE, Holliday MA, Wilson CJ, Salvatierra O, Beizer FO. Alternate-day steroids in children after renal transplantation. Transplant Proc 1975; 7: 79.
20. Dumler F, Levin NW, Szego G, Vulpetti AT, Preuss LE. Long-term alternate-day steroid therapy in renal transplantation. Transplantation 1982; 34: 78.
21. De Vecchi A, Cantaluppi A, Montagnino G, Tarantino A, Maestri O, Ponticelli C. Long-term comparison between single-morning daily and alternate-day steroid treatment in cadaver kidney recipients. Transplant Proc 1980; 12: 327.
22. McDonald FD, Horensten ML, Mayor GB, Turcotte JG, Selezinka W, Schork MA. Effect of alternate-day steroids on renal transplant function. A controlled study. Nephron 1976; 17: 415.
23. Rees L, Greene A, Adlard P, et al. Growth and endocrine function after renal transplantation. Arch Dis Child 1988; 63: 1326.